FSLLRY-NH2 是蛋白酶激活受体2(PAR2)抑制剂。
| 生物活性 | FSLLRY-NH2 is aprotease-activated receptor2 (PAR2)inhibitor[1]. |
体内研究
(In Vivo) | Treatment with FSLLRY-NH2 (50 μg per rat administered intranasally at 1 hour postresuscitation) significantly improves neurological outcome and reduces the number of degenerating hippocampal neurons after ACA (asphyxial CA)[1].
|
| 分子量 | |
| Formula | |
| CAS 号 | |
| Sequence | Phe-Ser-Leu-Leu-Arg-Tyr-NH2 |
| Sequence Shortening | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
